Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

A missense mutation in the neutrophil cytochrome b heavy chain in cytochrome-positive X-linked chronic granulomatous disease.
M C Dinauer, … , H Rosen, S H Orkin
M C Dinauer, … , H Rosen, S H Orkin
Published December 1, 1989
Citation Information: J Clin Invest. 1989;84(6):2012-2016. https://doi.org/10.1172/JCI114393.
View: Text | PDF
Research Article Article has an altmetric score of 3

A missense mutation in the neutrophil cytochrome b heavy chain in cytochrome-positive X-linked chronic granulomatous disease.

  • Text
  • PDF
Abstract

A membrane-bound cytochrome b, a heterodimer formed by a 91-kD glycoprotein and a 22-kD polypeptide, is a critical component of the phagocyte NADPH-oxidase responsible for the generation of superoxide anion. Mutations in the gene for the 91-kD chain of this cytochrome result in the X-linked form of chronic granulomatous disease (CGD), in which phagocytes are unable to produce superoxide. Typically, there is a marked deficiency of the 91-kD subunit and the cytochrome spectrum is absent (X- CGD). In a variant form of CGD with X-linked inheritance, affected males have a normal visible absorbance spectrum of cytochrome b, yet fail to generate superoxide (X+ CGD). The size and abundance of the mRNA for the 91-kD subunit and its encoded protein were examined and appeared normal. To search for a putative mutation in the coding sequence of the 91-kD subunit gene, the corresponding RNA from an affected X+ male was amplified by the polymerase chain reaction and sequenced. A single nucleotide change, a C----A transversion, was identified that predicts a nonconservative Pro----His substitution at residue 415 of the encoded protein. Hybridization of amplified genomic DNA with allele-specific oligonucleotide probes demonstrated the mutation to be specific to affected X+ males and the carrier state. These results strengthen the concept that all X-linked CGD relates to mutations affecting the expression or structure of the 91-kD cytochrome b subunit. The mechanism by which the Pro 415----His mutation renders the oxidase nonfunctional is unknown, but may involve an impaired interaction with other components of the oxidase.

Authors

M C Dinauer, J T Curnutte, H Rosen, S H Orkin

×

Total citations by year

Year: 2022 2021 2020 2019 2017 2016 2014 2013 2012 2011 2010 2008 2007 2006 2005 2004 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 Total
Citations: 1 8 1 16 1 1 2 1 14 2 5 1 1 2 2 1 2 3 1 2 5 4 3 7 8 6 15 13 3 131
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (131)

Title and authors Publication Year
Variant Type X91+ Chronic Granulomatous Disease: Clinical and Molecular Characterization in a Chinese Cohort.
Sun B, Zhu Z, Hui X, Sun J, Wang W, Ying W, Zhou Q, Yao H, Hou J, Wang X
Journal of Clinical Immunology 2022
Microbial Pathogenesis: Infection and Immunity
U Kishore
2021
Microbial Pathogenesis: Infection and Immunity
U Kishore
2021
Microbial Pathogenesis: Infection and Immunity
U Kishore
2021
Microbial Pathogenesis: Infection and Immunity
U Kishore
2021
Microbial Pathogenesis: Infection and Immunity
U Kishore
2021
Microbial Pathogenesis: Infection and Immunity
U Kishore
2021
Microbial Pathogenesis: Infection and Immunity
U Kishore
2021
Microbial Pathogenesis: Infection and Immunity
U Kishore
2021
Nox4 regulates InsP 3 receptor‐dependent Ca 2+ release into mitochondria to promote cell survival
M Beretta, CX Santos, C Molenaar, AD Hafstad, CC Miller, A Revazian, K Betteridge, K Schröder, K StreckfußBömeke, JH Doroshow, RA Fleck, TP Su, VV Belousov, M Parsons, AM Shah
The EMBO Journal 2020
NADPH Oxidases: Methods and Protocols
UG Knaus, TL Leto
2019
NADPH Oxidases: Methods and Protocols
UG Knaus, TL Leto
2019
NADPH Oxidases: Methods and Protocols
UG Knaus, TL Leto
2019
NADPH Oxidases: Methods and Protocols
UG Knaus, TL Leto
2019
NADPH Oxidases: Methods and Protocols
UG Knaus, TL Leto
2019
NADPH Oxidases: Methods and Protocols
UG Knaus, TL Leto
2019
NADPH Oxidases: Methods and Protocols
UG Knaus, TL Leto
2019
NADPH Oxidases: Methods and Protocols
UG Knaus, TL Leto
2019
NADPH Oxidases: Methods and Protocols
UG Knaus, TL Leto
2019
NADPH Oxidases: Methods and Protocols
UG Knaus, TL Leto
2019
NADPH Oxidases: Methods and Protocols
UG Knaus, TL Leto
2019
NADPH Oxidases: Methods and Protocols
UG Knaus, TL Leto
2019
NADPH Oxidases: Methods and Protocols
UG Knaus, TL Leto
2019
NADPH Oxidases: Methods and Protocols
UG Knaus, TL Leto
2019
NADPH Oxidases: Methods and Protocols
UG Knaus, TL Leto
2019
NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets
Y Zhang, P Murugesan, K Huang, H Cai
Nature Reviews Cardiology 2019
Protective Role for Macrophages in Respiratory Francisella tularensis Infection
DJ Steiner, Y Furuya, MB Jordan, DW Metzger, CR Roy
Infection and immunity 2017
Targeted redox inhibition of protein phosphatase 1 by Nox4 regulates eIF2 -mediated stress signaling
CX Santos, AD Hafstad, M Beretta, M Zhang, C Molenaar, J Kopec, D Fotinou, TV Murray, AM Cobb, D Martin, MZ Silva, N Anilkumar, K Schro der, CM Shanahan, AC Brewer, RP Brandes, E Blanc, M Parsons, V Belousov, R Cammack, RC Hider, RA Steiner, AM Shah
The EMBO Journal 2016
NADPH Oxidase 4 Induces Cardiac Arrhythmic Phenotype in Zebrafish
Y Zhang, H Shimizu, KL Siu, A Mahajan, JN Chen, H Cai
The Journal of biological chemistry 2014
Primary Immunodeficiency Caused by an Exonized Retroposed Gene Copy Inserted in the CYBB Gene
M Boer, K Leeuwen, J Geissler, CM Weemaes, TK van Berg, TW Kuijpers, A Warris, D Roos
Human Mutation 2014
From Bench to Bedside: Preclinical Evaluation of a Self-Inactivating Gammaretroviral Vector for the Gene Therapy of X-linked Chronic Granulomatous Disease
S Stein, S Scholz, J Schwäble, MA Sadat, U Modlich, S Schultze-Strasser, M Diaz, L Chen-Wichmann, U Müller-Kuller, C Brendel, R Fronza, KB Kaufmann, S Naundorf, NK Pech, JB Travers, JD Matute, RG Presson, GE Sandusky, H Kunkel, E Rudolf, A Dillmann, C von Kalle, K Kühlcke, C Baum, A Schambach, MC Dinauer, M Schmidt, M Grez
Human Gene Therapy Clinical Development 2013
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Molecular Dermatology
C Has, C Sitaru
2012
Extensive Natural Variation for Cellular Hydrogen Peroxide Release Is Genetically Controlled
H Attar, K Bedard, E Migliavacca, M Gagnebin, Y Dupré, P Descombes, C Borel, S Deutsch, H Prokisch, T Meitinger, D Mehta, E Wichmann, JM Delabar, ET Dermitzakis, KH Krause, SE Antonarakis
PloS one 2012
Afa/Dr Diffusely Adhering Escherichia coli Strain C1845 Induces Neutrophil Extracellular Traps That Kill Bacteria and Damage Human Enterocyte-Like Cells
V Marin-Esteban, I Turbica, G Dufour, N Semiramoth, A Gleizes, R Gorges, I Beau, AL Servin, VL Moal, C Sandré, S Chollet-Martin, SM Payne
Infection and immunity 2012
The Human NADPH Oxidase: Primary and Secondary Defects Impairing the Respiratory Burst Function and the Microbicidal Ability of Phagocytes
EB de Oliveira-Junior, J Bustamante, PE Newburger, A Condino-Neto
Scandinavian Journal of Immunology 2011
Nox5 Forms a Functional Oligomer Mediated by Self-Association of Its Dehydrogenase Domain
T Kawahara, HM Jackson, SM Smith, PD Simpson, JD Lambeth
Biochemistry 2011
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease
S Stein, MG Ott, S Schultze-Strasser, A Jauch, B Burwinkel, A Kinner, M Schmidt, A Krämer, J Schwäble, H Glimm, U Koehl, C Preiss, C Ball, H Martin, G Göhring, K Schwarzwaelder, WK Hofmann, K Karakaya, S Tchatchou, R Yang, P Reinecke, K Kühlcke, B Schlegelberger, AJ Thrasher, D Hoelzer, R Seger, C von Kalle, M Grez
Nature Medicine 2010
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
VG Fowler, WM Scheld, AS Bayer
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 2010
Hematologically important mutations: X-linked chronic granulomatous disease (third update)
D Roos, DB Kuhns, A Maddalena, J Roesler, JA Lopez, T Ariga, T Avcin, M Boer, J Bustamante, A Condino-Neto, GD Matteo, J He, HR Hill, SM Holland, C Kannengiesser, MY Köker, I Kondratenko, K Leeuwen, HL Malech, L Marodi, H Nunoi, MJ Stasia, AM Ventura, CT Witwer, B Wolach, JI Gallin
Blood Cells, Molecules, and Diseases 2010
National Institute of Allergy and Infectious Diseases, NIH
VS Georgiev
2010
Afa/Dr-Expressing, Diffusely Adhering Escherichia coli Strain C1845 Triggers F1845 Fimbria-Dependent Phosphatidylserine Externalization on Neutrophil-Like Differentiated PLB-985 Cells through an Apoptosis-Independent Mechanism
N Sémiramoth, A Gleizes, I Turbica, C Sandré, V Marin-Esteban, R Gorges, A Servin, S Chollet-Martin
Infection and immunity 2010
Genetics and immunopathology of chronic granulomatous disease
MJ Stasia, XJ Li
Seminars in Immunopathology 2008
La granulomatose septique chronique X +: Un fabuleux modèle d’étude de l’activation du complexe NADPH oxydase
MJ Stasia
médecine/sciences 2007
Advances in Enzymology - and Related Areas of Molecular Biology
H Waelsch
Advances in Enzymology and Related Areas of Molecular Biology 2006
Leu505 of Nox2 is crucial for optimal p67 phox -dependent activation of the flavocytochrome b558 during phagocytic NADPH oxidase assembly
XJ Li, F Fieschi, MH Paclet, D Grunwald, Y Campion, P Gaudin, F Morel, MJ Stasia
Journal of leukocyte biology 2006
Myeloperoxidase: friend and foe
SJ Klebanoff
Journal of leukocyte biology 2005
The NADPH Oxidase Nox3 Constitutively Produces Superoxide in a p22 phox -dependent Manner: ITS REGULATION BY OXIDASE ORGANIZERS AND ACTIVATORS
N Ueno, R Takeya, K Miyano, H Kikuchi, H Sumimoto
The Journal of biological chemistry 2005
Molecular Analysis of X-linked Chronic Granulomatous Disease in Five Unrelated Korean Patients
HB Oh, JS Park, W Lee, SJ Yoo, JH Yang, SY Oh
Journal of Korean Medical Science 2004
mRNA Expression Profiles for Escherichia coli Ingested by Normal and Phagocyte Oxidase-Deficient Human Neutrophils
BJ Staudinger, MA Oberdoerster, P Lewis, H Rosen
Journal of Clinical Investigation 2002
Molecular and functional characterization of a new X-linked chronic granulomatous disease variant (X91+) case with a double missense mutation in the cytosolic gp91phox C-terminal tail
Marie José Stasia, Bernard Lardy, Andres Maturana, Pascale Rousseau, Cécile Martel, Pierre Bordigoni, Nicolas Demaurex, Françoise Morel
Biochimica et Biophysica Acta 2002
Superoxide generation of phagocytes and nonphagocytic cells
B Meier
Protoplasma 2001
Hematologically Important Mutations: X-Linked Chronic Granulomatous Disease (Second Update)
PG Heyworth, JT Curnutte, J Rae, D Noack, D Roos, E Koppen, AR Cross
Blood Cells, Molecules, and Diseases 2001
Improved superoxide-generating ability by interferon γ due to splicing pattern change of transcripts in neutrophils from patients with a splice site mutation inCYBB gene
F Ishibashi, T Mizukami, S Kanegasaki, L Motoda, R Kakinuma, F Endo, H Nunoi
Blood 2001
Genetic, Biochemical, and Clinical Features of Chronic Granulomatous Disease
BH Segal, TL Leto, JI Gallin, HL Malech, SM Holland
Medicine 2000
Molecular and Cellular Basis of Inflammation
CN Serhan, PA Ward
1999
Missense Mutations in the gp91-phox Gene Encoding Cytochromeb558 in Patients With Cytochrome b Positive and Negative X-Linked Chronic Granulomatous Disease
M Kaneda, H Sakuraba, A Ohtake, A Nishida, C Kiryu, K Kakinuma
Blood 1999
X-Linked Chronic Granulomatous Disease: Mutations in the CYBB Gene Encoding the gp91-phox Component of Respiratory-Burst Oxidase
J Rae, PE Newburger, MC Dinauer, D Noack, PJ Hopkins, R Kuruto, JT Curnutte
The American Journal of Human Genetics 1998
PU.1 as an essential activator for the expression of gp91(phox) gene in human peripheral neutrophils, monocytes, and B lymphocytes
S Suzuki, A Kumatori, IA Haagen, Y Fujii, MA Sadat, HL Jun, Y Tsuji, D Roos, M Nakamura
Proceedings of the National Academy of Sciences 1998
Genetic Analysis of 13 Families with X-Linked Chronic Granulomatous Disease Reveals a Low Proportion of Sporadic Patients and a High Proportion of Sporadic Carriers
T Ariga, H Furuta, K Cho, Y Sakiyama
Pediatric Research 1998
PU.1 as an essential activator for the expression of gp91phox gene in human peripheral neutrophils, monocytes, and B lymphocytes
S Suzuki, A Kumatori, IA Haagen, Y Fujii, MA Sadat, HL Jun, Y Tsuji, D Roos, M Nakamura
Proceedings of the National Academy of Sciences 1998
Mutation at Histidine 338 of gp91 phox Depletes FAD and Affects Expression of Cytochrome b558 of the Human NADPH Oxidase
LS Yoshida, F Saruta, K Yoshikawa, O Tatsuzawa, S Tsunawaki
The Journal of biological chemistry 1998
An in-frame triplet deletion within the gp91-phox gene in an adult X-linked chronic granulomatous disease patient with residual NADPH-oxidase activity
V Jendrossek, A Ritzel, B Neubauer, S Heyden, M Gahr
European Journal of Haematology 1997
Redundant contribution of myeloperoxidase-dependent systems to neutrophil-mediated killing of Escherichia coli
H Rosen, BR Michel
Infection and immunity 1997
Hematologically Important Mutations: X-Linked Chronic Granulomatous Disease—An Update
PG Heyworth, JT Curnutte, J Rae, D Noack, AR Cross
Blood Cells, Molecules, and Diseases 1997
Klinische Biochemie
RF Ludueña
1997
NADPH oxidase of neutrophils
LM Henderson, JB Chappell
Biochimica et Biophysica Acta (BBA) - Bioenergetics 1996
Interactions between the components of the human nadph oxidase: intrigues in the phox family
JH Leusen, AJ Verhoeven, D Roos
Journal of Laboratory and Clinical Medicine 1996
Blood Cell Biochemistry
AD Whetton, J Gordon
1996
Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden
A Åhlin, M Boer, D Roos, J Leusen, CI Smith, U Sundin, H Rabbani, J Palmblad, G Elinder
Acta Paediatrica 1995
Low NADPH oxidase activity in Epstein-Barr-virus-immortalized B-lymphocytes is due to a post-transcriptional block in expression of cytochrome b558
M Chetty, AJ Thrasher, A Abo, CM Casimir
Biochemical Journal 1995
Chronic Granulomatous Disease: Pathogenesis and Management
RA Ezekowitz, Q Eichbaum
Clinical immunotherapeutics 1995
A Variant X-linked Chronic Granulomatous Disease Patient (X91 + ) with Partially Functional Cytochrome b
AR Cross, PG Heyworth, J Rae, JT Curnutte
The Journal of biological chemistry 1995
A 15-base pair (bp) palindromic insertion associated with a 3-bp deletion in exon 10 of the gp91-phox gene, detected in two patients with X-linked chronic granulomatous disease
T Ariga, Y Sakiyama, S Matsumoto
Human Genetics 1995
Update on selected inherited immunodeficiency syndromes
AS Paller
Seminars in Dermatology 1995
The NADPH oxidase complex of phagocytic leukocytes: a biochemical and cytochemical view
JM Robinson, JA Badwey
Histochemistry 1995
Activation of H+ conductance in neutrophils requires assembly of components of the respiratory burst oxidase but not its redox function
A Nanda, JT Curnutte, S Grinstein
Journal of Clinical Investigation 1994
A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox
JH Leusen, M Boer, BG Bolscher, PM Hilarius, RS Weening, HD Ochs, D Roos, AJ Verhoeven
Journal of Clinical Investigation 1994
Mutations in the promoter region of the gene for gp91-phox in X-linked chronic granulomatous disease with decreased expression of cytochrome b558
PE Newburger, DG Skalnik, PJ Hopkins, EA Eklund, JT Curnutte
Journal of Clinical Investigation 1994
Mechanisms for the activation/electron transfer of neutrophil NADPH-oxidase complex and molecular pathology of chronic granulomatous disease
S Umeki
Annals of Hematology 1994
Molecular genetic studies of two families with X-linked chronic granulomatous disease: Mutation analysis and definitive determination of carrier status in patients' sisters
T Ariga, Y Sakiyama, H Furuta, S Matsumoto
European Journal of Haematology 1994
The Genetic Basis of Chronic Granulomatous Disease
D Roos
Immunological Reviews 1994
Inactivation of Escherichia coli penicillin-binding proteins by human neutrophils
RM Rakita, BR Michel, H Rosen
Infection and immunity 1994
Two novel point mutations in the cytochrome b 558 heavy chain gene, detected in two Japanese patients with X-linked chronic granulomatous disease
T Ariga, Y Sakiyama, S Matsumoto
Human Genetics 1994
In vitro molecular reconstitution of the respiratory burst in B lymphoblasts from p47-phox-deficient chronic granulomatous disease
BD Volpp, Y Lin
Journal of Clinical Investigation 1993
A newly recognized point mutation in the cytochrome b558 heavy chain gene replacing alanine57 by glutamic acid, in a patient with cytochrome b positive X-linked chronic granulomatous disease
T Ariga, Y Sakiyama, K Tomizawa, S Imajoh-Ohmi, S Kanegasaki, S Matsumoto
European Journal of Pediatrics 1993
A 40-base-pair duplication in the gp91-phox gene leading to X-linked chronic granulomatous disease
H Rabbani, M Boer, A Åhlin, U Sundin, G Elinder, L Hammarström, J Palmblad, CI Smith, D Roos
European Journal of Haematology 1993
Gene targeting of X chromosome-linked chronic granulomatous disease locus in a human myeloid leukemia cell line and rescue by expression of recombinant gp91phox
L Zhen, AA King, Y Xiao, SJ Chanock, SH Orkin, MC Dinauer
Proceedings of the National Academy of Sciences 1993
The Polymerase Chain Reaction: Applications in Dermatology
JL Snow, K Snow, MR Pittelkow
The Journal of Dermatologic Surgery and Oncology 1993
The Respiratory Burst Oxidase and the Molecular Genetics of Chronic Granulomatous Disease
MC Dinauer, PE Newburger
Critical Reviews in Clinical Laboratory Sciences 1993
Identification of a thermolabile component of the human neutrophil NADPH oxidase. A model for chronic granulomatous disease caused by deficiency of the p67-phox cytosolic component
RW Erickson, SE Malawista, MC Garrett, GV Blaricom, TL Leto, JT Curnutte
Journal of Clinical Investigation 1992
Chronic granulomatous disease
RA Seger, F Berthet, JP Hossie
Pediatric Allergy and Immunology 1992
Cytochrome b positive X-linked chronic granulomatous disease: A normal cell surface expression of cytochrome b
H Azuma, H Oomi, D Ueda, K Sasaki, Y Makita, K Tomizawa, Y Sakiyama, K Fujita, H Yoshioka, A Okuno
European Journal of Pediatrics 1992
Identification of the defective NADPH-oxidase component in Chronic Granulomatous Disease: a study of 57 European families
C Casimir, M Chetty, MC Bohler, R Garcia, A Fischer, C Griscelli, B Johnson, AW Segal
European Journal of Clinical Investigation 1992
Discoid lupus erythematosus in an X-linked cytochrome-positive carrier of chronic granulomatous disease
GR Yeaman, K Froebel, G Galea, A Ormerod, SJ Urbaniak
British Journal of Dermatology 1992
Delineation of the phagocyte NADPH oxidase through studies of chronic granulomatous diseases of childhood
JI Gallin, TL Leto, D Rotrosen, CH Kwong, HL Malech
Current Opinion in Immunology 1992
Prenatal diagnosis in a family with X-linked chronic granulomatous disease with the use of the polymerase chain reaction
MD Boer, BG Bolscher, RH Sijmons, H Scheffer, RS Weening, D Roos
Prenatal Diagnosis 1992
Cytochrome b-245 is a flavocytochrome containing FAD and the NADPH-binding site of the microbicidal oxidase of phagocytes
AW Segal, I West, F Wientjes, JH Nugent, AJ Chavan, B Haley, RC Garcia, H Rosen, G Scrace
Biochemical Journal 1992
Biological Oxidants: Generation and Injurious Consequences
AW Segal, JH Nugent
Biological Oxidants: Generation and Injurious Consequences 1992
Cytochrome b558, a component of the phagocyte NADPH oxidase, is a flavoprotein
H Sumimoto, N Sakamoto, M Nozaki, Y Sakaki, K Takeshige, S Minakami
Biochemical and Biophysical Research Communications 1992
Chronic Granulomatous Disease: Diagnosis and Classification at the Molecular Level
PJ Hopkins, LS Bemiller, JT Curnutte
Clinics in Laboratory Medicine 1992
Mononuclear Phagocytes
R van Furth
1992
Baculovirus mediated expression of human phagocytic cell oxidase cytochrome b558 in sf9 insect cells
JP Katkin, HL Malech, TL Leto
Inflammation 1992
Macrophage Biology and Activation
SW Russell, S Gordon
1992
Cytochrome b 558 : the Flavin-Binding Component of the Phagocyte NADPH Oxidase
D Rotrosen, CL Yeung, TL Leto, HL Malech, CH Kwong
Science 1992
Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558
PG Heyworth, JT Curnutte, WM Nauseef, BD Volpp, DW Pearson, H Rosen, RA Clark
Journal of Clinical Investigation 1991
The superoxide-generating oxidase of phagocytic cells. Physiological, molecular and pathological aspects
F MOREL, J DOUSSIERE, PV VIGNAIS
European Journal of Biochemistry 1991
The respiratory burst oxidase and the molecular basis of chronic granulomatous disease
BM Babior
American Journal of Hematology 1991
Interferon-γ and chronic granulomatous disease
MC Dinauer, RA Ezekowitz
Current Opinion in Immunology 1991
Gene Amplification by Polymerase Chain Reaction in Dermatology
D Schadendorf, BM Czarnetzki
Journal of Investigative Dermatology 1991
The expression of 22-kD subunit of cytochrome b558 in patients with X-linked chronic granulomatous disease
K Tomizawa, Y Sakiyama, S Matsumoto, M Nakamura
European Journal of Haematology 1991
Kinetics of transfused neutrophils in peripheral blood and BAL fluid of a patient with variant X-linked chronic granulomatous disease
A Emmendorffer, ML Lohmann-Matthes, J Roesler
European Journal of Haematology 1991
Point mutation in the cytoplasmic domain of the neutrophil p22-phox cytochrome b subunit is associated with a nonfunctional NADPH oxidase and chronic granulomatous disease
MC Dinauer, EA Pierce, RW Erickson, TJ Muhlebach, H Messner, SH Orkin, RA Seger, JT Curnutte
Proceedings of the National Academy of Sciences 1991
Inactivation of NADPH oxidase from human neutrophils by affinity labelling with pyridoxal 5′-diphospho-5′-adenosine
P Ravel, F Lederer
Biochemical and Biophysical Research Communications 1991
Chronic Granulomatous Disease Presenting in a 69-Year-Old Man
BL Schapiro, PE Newburger, MS Klempner, MC Dinauer
New England Journal of Medicine 1991
EJB Reviews 1991
P Christen, E Hofmann
1991
Assembly of the neutrophil respiratory burst oxidase. Protein kinase C promotes cytoskeletal and membrane association of cytosolic oxidase components
WM Nauseef, BD Volpp, S McCormick, KG Leidal, RA Clark
The Journal of biological chemistry 1991
Resonance Raman and electron paramagnetic resonance structural investigations of neutrophil cytochrome b558
JK Hurst, TM Loehr, JT Curnutte, H Rosen
The Journal of biological chemistry 1991
Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease
MC Dinauer, EA Pierce, GA Bruns, JT Curnutte, SH Orkin
Journal of Clinical Investigation 1990
The polymerase chain reaction: Miracle or mirage? A critical review of its uses and limitations in diagnosis and research
PA Wright, D Wynford-Thomas
The Journal of Pathology 1990
Genes for two autosomal recessive forms of chronic granulomatous disease assigned to 1q25 (NCF2) and 7q11.23 (NCF1)
U Francke, CL Hsieh, BE Foellmer, KJ Lomax, HL Malech, TL Leto
The American Journal of Human Genetics 1990

← Previous 1 2 3 4 5 6 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 3 Wikipedia pages
24 readers on Mendeley
See more details